Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
NEURIZON THERAPEUTICS LIMITED
HEALEY ALS Platform Trial Regimen I expands to 240 participants
May 27, 2026
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
December 13, 2025
Elanco executive appointed as Neurizon’s Board Observer
November 28, 2025